Carregant...
Optimum Design of Disease-modifying Trials on Alzheimer’s Disease
Randomized start and withdrawal designs have been recently proposed to test the disease-modifying agents on Alzheimer’s disease (AD). This article provides methods to determine the optimum parameters for these designs. A general linear mixed effects model is proposed. This model employs a piecewise...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3634601/ https://ncbi.nlm.nih.gov/pubmed/23626866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19466315.2011.634757 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|